Financial Advisor
Belmar Pharmacies
M&A Advisory
Has Been Acquired By
Transaction Details
- On April 22, 2019, Belmar Pharmacies (“Belmar” or the “Company”) was acquired by Webster Equity Partners and MedEquity Capital
- Belmar is a specialty pharmacy platform that specializes in Bio-Identical Hormone Replacement Therapy (“BHRT”) and other hormone-based wellness products. Belmar services ~6,500 providers and ~64,000 patients annually across 46 states out of both 503A and 503B facilities
- Both Webster and MedEquity are committed to provide a significant amount of additional capital to enable Belmar’s strategy of sector leadership through follow-on acquisitions
- Terms of the transaction were not disclosed
- Stephens Inc. served as exclusive financial advisor to Belmar Pharmacies
About the company
Belmar Pharmacies
Belmar Pharmacy is a compounding pharmacy located in Golden, CO. Since 1985, Belmar Pharmacy has specialized in compounding bio-identical hormones and is respected nationally as dosage form experts. Belmar’s goal is better patient outcomes, through quality traditional compounding, and effective communication between practitioner, pharmacist, and patient.
Webster Capital
Founded in 2003, Webster Equity Partners is a private equity firm that invests in the branded consumer and healthcare services industries and provides equity financing, expertise, and a broad contact network for management buyouts and growth capital. Webster is currently investing out of its fourth fund with $875 million of committed capital. For additional information on Webster Equity Partners, please visit www.websterequitypartners.com.
MedEquity Capital
MedEquity Capital is a healthcare private equity firm that focuses on investing in profitable healthcare services, distribution, and products companies. Since its founding 20 years ago, MedEquity has invested hundreds of millions of capital in over two dozen companies with top decile equity returns. For more information, please visit www.medequity.com.
Sources: Press Releases and Company Materials
-
This material has been prepared solely for informative purposes as of its stated date and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from external sources which we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. Such information is believed to be accurate on the date of issuance of the material. No subsequent publication or distribution of this material shall mean or imply that any such information or opinion remains current at any time after the stated date of the material. We do not undertake to advise you of any changes in any such information or opinion. Additional information is available upon request.